NRx Pharmaceuticals (NRXP) Institutional Ownership → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free NRXP Stock Alerts $3.81 +0.13 (+3.53%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)CurrentInstitutional OwnershipPercentage4.27%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$36.02MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$9.74M Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXP Institutional Buying and Selling by Quarter Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here NRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024 AdvisorShares Investments LLC642,632$296K0.1%N/A0.755% 1/25/2024 One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165% 11/15/2023 Sabby Management LLC325,000$84K0.1%-53.6%0.398% 5/1/2023 Virtu Financial LLC46,210$30K0.0%N/A0.065% 2/9/2023 HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086% 1/31/2023 AE Wealth Management LLC29,515$33K0.0%N/A0.044% 1/27/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 1/18/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 11/3/2022 Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094% 5/18/2022 Ursa Fund Management LLC15,000$37K0.0%N/A0.023% 4/29/2022 United Asset Strategies Inc.18,300$45K0.0%N/A0.027% 2/9/2022 Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063% 2/8/2022 Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020% 11/15/2021 Penserra Capital Management LLC2,956$27K0.0%N/A0.005% 11/12/2021 Wolverine Asset Management LLC42,568$394K0.0%+118.4%0.079% 11/5/2021 Advisor Group Holdings Inc.42,885$398K0.0%+1,197.6%0.080% 11/2/2021 Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285% 8/16/2021 Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626% 8/16/2021 Ionic Capital Management LLC35,721$415K0.0%N/A0.075% 8/16/2021 Linden Advisors LP364,352$4.23M0.0%N/A0.760% 8/13/2021 Northern Trust Corp130,633$1.52M0.0%N/A0.273% 8/13/2021 Yakira Capital Management Inc.11,923$139K0.0%N/A0.025% 8/13/2021 Geode Capital Management LLC34,475$400K0.0%N/A0.072% 8/13/2021 Vanguard Group Inc.637,416$7.41M0.0%N/A1.330% (Data available from 1/1/2016 forward) NRXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXP shares? During the previous two years, the following institutional investors and hedge funds held shares of NRx Pharmaceuticals shares: AdvisorShares Investments LLC ($296K), Sabby Management LLC ($84K), One Wealth Management Investment & Advisory Services LLC ($65K), HBK Sorce Advisory LLC ($65K), Texas Capital Bank Wealth Management Services Inc. ($47K), AE Wealth Management LLC ($33K), and Virtu Financial LLC ($30K).Learn more on NRXP's institutional investors. What percentage of NRx Pharmaceuticals stock is owned by institutional investors? 4.27% of NRx Pharmaceuticals stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings. Which institutional investors have been buying NRx Pharmaceuticals stock? The following institutional investors have purchased NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($642.63K), One Wealth Management Investment & Advisory Services LLC ($140.40K), Texas Capital Bank Wealth Management Services Inc. ($63.29K), HBK Sorce Advisory LLC ($58.46K), Virtu Financial LLC ($46.21K), Exchange Traded Concepts LLC ($32.64K), and AE Wealth Management LLC ($29.52K). How much institutional buying is happening at NRx Pharmaceuticals? Institutional investors have bought a total of 1,013,153 shares in the last 24 months. This purchase volume represents approximately $57.14M in transactions. Which NRx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: Sabby Management LLC ($374.73K). How much institutional selling is happening at NRx Pharmaceuticals? Institutional investors have sold a total of 374,731 shares in the last 24 months. This volume of shares sold represents approximately $9.74M in transactions. Related Companies: Cara Therapeutics Major Shareholders CASI Pharmaceuticals Major Shareholders HCW Biologics Major Shareholders DURECT Major Shareholders Eyenovia Major Shareholders Daré Bioscience Major Shareholders Fortress Biotech Major Shareholders VYNE Therapeutics Major Shareholders Unicycive Therapeutics Major Shareholders Lexaria Bioscience Major Shareholders This page (NASDAQ:NRXP) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.